Immunovant, Inc. IMVT Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s shares (diluted)?
- Immunovant, Inc. (IMVT) reported shares (diluted) of 182.4M in Q1 2026.
- How has Immunovant, Inc.'s shares (diluted) changed year-over-year?
- Immunovant, Inc.'s shares (diluted) increased by 20.4% year-over-year, from 151.6M to 182.4M.
- What is the long-term trend for Immunovant, Inc.'s shares (diluted)?
- Over 4 years (2022 to 2026), Immunovant, Inc.'s shares (diluted) has grown at a 13.2% compound annual growth rate (CAGR), from 431.8M to 708.5M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.